MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Iwamoto, T.
Right arrow Articles by Shigekawa, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Iwamoto, T.
Right arrow Articles by Shigekawa, M.

Vol. 59, Issue 3, 524-531, March 2001

Structural Domains Influencing Sensitivity to Isothiourea Derivative Inhibitor KB-R7943 in Cardiac Na+/Ca2+ Exchanger

Takahiro Iwamoto, Satomi Kita, Akira Uehara, Yutaka Inoue, Yuki Taniguchi, Issei Imanaga, and Munekazu Shigekawa

Department of Molecular Physiology, National Cardiovascular Center Research Institute, Osaka, Japan (T.I., S.K., Y.I., Y.T., M.S.); and Department of Physiology, School of Medicine, Fukuoka University, Fukuoka, Japan (A.U., I.I.)

KB-R7943 (2-[2-[4-(4-nitrobenzyloxy)phenyl]ethyl]isothiourea methanesulfonate) is a potent and selective Na+/Ca2+ exchange (NCX) inhibitor that is 3-fold more inhibitory to NCX3 than to NCX1 or NCX2. Here we searched for amino acid residues that may form the KB-R7943 receptor in the exchanger by analyzing the function of chimeras between NCX1 and NCX3 as well as of their site-directed mutants. We found that the highly conserved alpha -2 repeat of the exchanger is almost exclusively responsible for the difference in drug response of the isoforms. Such difference was mostly reproduced by single substitutions of residues in the alpha -2 repeat (V820G or Q826V in NCX1 and A809V or A809I in NCX3), suggesting their importance in drug sensitivity. Cysteine scanning mutagenesis of the alpha -2 repeat of NCX1 identified one residue (Gly833) that caused a large (>=  30-fold) reduction in drug sensitivity. We found that the Gly-to-Thr substitution caused even larger reduction in drug sensitivity. Interestingly, extracellularly applied KB-R7943 at 0.8 µM markedly inhibited the whole-cell outward exchange current, whereas the drug applied intracellularly at 30 µM did not. These results suggest that KB-R7943 inhibits the exchanger from the external side in intact cells and that a region of the alpha -2 repeat of NCX1 containing Gly833 may participate in the formation of the drug receptor. Because we suggested previously that Gly833 is accessible from the inside of a cell, the results raised an interesting possibility that this residue may alter its position during Na+/Ca2+ exchange in such a way that it becomes accessible to external drug.


Copyright © 2001 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
T. Iwamoto and S. Kita
YM-244769, a Novel Na+/Ca2+ Exchange Inhibitor That Preferentially Inhibits NCX3, Efficiently Protects against Hypoxia/Reoxygenation-Induced SH-SY5Y Neuronal Cell Damage
Mol. Pharmacol., December 1, 2006; 70(6): 2075 - 2083.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
T. Kawada, T. Yamazaki, T. Akiyama, K. Uemura, A. Kamiya, T. Shishido, H. Mori, and M. Sugimachi
Effects of Ca2+ channel antagonists on nerve stimulation-induced and ischemia-induced myocardial interstitial acetylcholine release in cats
Am J Physiol Heart Circ Physiol, November 1, 2006; 291(5): H2187 - H2191.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
T. Iwamoto
Vascular Na+/Ca2+ exchanger: implications for the pathogenesis and therapy of salt-dependent hypertension
Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2006; 290(3): R536 - R545.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
R. Dipolo and L. Beauge
Sodium/Calcium Exchanger: Influence of Metabolic Regulation on Ion Carrier Interactions
Physiol Rev, January 1, 2006; 86(1): 155 - 203.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
L. Beauge and R. DiPolo
SEA-0400, a potent inhibitor of the Na+/Ca2+ exchanger, as a tool to study exchanger ionic and metabolic regulation
Am J Physiol Cell Physiol, June 1, 2005; 288(6): C1374 - C1380.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
S. Zhang, J. X.-J. Yuan, K. E. Barrett, and H. Dong
Role of Na+/Ca2+ exchange in regulating cytosolic Ca2+ in cultured human pulmonary artery smooth muscle cells
Am J Physiol Cell Physiol, February 1, 2005; 288(2): C245 - C252.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
L. Annunziato, G. Pignataro, and G. F. Di Renzo
Pharmacology of Brain Na+/Ca2+ Exchanger: From Molecular Biology to Therapeutic Perspectives
Pharmacol. Rev., December 1, 2004; 56(4): 633 - 654.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
T. Iwamoto, Y. Inoue, K. Ito, T. Sakaue, S. Kita, and T. Katsuragi
The Exchanger Inhibitory Peptide Region-Dependent Inhibition of Na+/Ca2+ Exchange by SN-6 [2-[4-(4-Nitrobenzyloxy)benzyl]thiazolidine-4-carboxylic Acid Ethyl Ester], a Novel Benzyloxyphenyl Derivative
Mol. Pharmacol., July 1, 2004; 66(1): 45 - 55.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
R. Bouchard, A. Omelchenko, H. D. Le, P. Choptiany, T. Matsuda, A. Baba, K. Takahashi, D. A. Nicoll, K. D. Philipson, M. Hnatowich, et al.
Effects of SEA0400 on Mutant NCX1.1 Na+-Ca2+ Exchangers with Altered Ionic Regulation
Mol. Pharmacol., March 1, 2004; 65(3): 802 - 810.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Iwamoto, S. Kita, A. Uehara, I. Imanaga, T. Matsuda, A. Baba, and T. Katsuragi
Molecular Determinants of Na+/Ca2+ Exchange (NCX1) Inhibition by SEA0400
J. Biol. Chem., February 27, 2004; 279(9): 7544 - 7553.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. Miyata, D. P. Zipes, S. Hall, and M. Rubart
KB-R7943 Prevents Acute, Atrial Fibrillation-Induced Shortening of Atrial Refractoriness in Anesthetized Dogs
Circulation, September 10, 2002; 106(11): 1410 - 1419.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
H. Reuter, S. A. Henderson, T. Han, T. Matsuda, A. Baba, R. S. Ross, J. I. Goldhaber, and K. D. Philipson
Knockout Mice for Pharmacological Screening: Testing the Specificity of Na+-Ca2+ Exchange Inhibitors
Circ. Res., July 26, 2002; 91(2): 90 - 92.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C. L. Elias, A. Lukas, S. Shurraw, J. Scott, A. Omelchenko, G. J. Gross, M. Hnatowich, and L. V. Hryshko
Inhibition of Na+/Ca2+ exchange by KB-R7943: transport mode selectivity and antiarrhythmic consequences
Am J Physiol Heart Circ Physiol, September 1, 2001; 281(3): H1334 - H1345.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. J Conway and S. V Koushik
Cardiac sodium-calcium exchanger: a double-edged sword
Cardiovasc Res, August 1, 2001; 51(2): 194 - 197.
[Full Text] [PDF]


Home page
Circ. Res.Home page
M. Shigekawa and T. Iwamoto
Cardiac Na+-Ca2+ Exchange : Molecular and Pharmacological Aspects
Circ. Res., May 11, 2001; 88(9): 864 - 876.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2001 by the American Society for Pharmacology and Experimental Therapeutics